Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI
Authors not listed
Johns Hopkins University · 2009
Abstract
This research is being done to find out if daily use of the drug levetiracetam can improve memory function in individuals with memory problems like those associated with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Anonymous. (2009). Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI. <em>Johns Hopkins University</em>. https://clinicaltrials.gov/study/NCT01044758
Vancouver
Anonymous. Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI. Johns Hopkins University. 2009.
BibTeX
@misc{anon2009Bridgi,
title = {Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI},
author = {Anonymous},
journal = {Johns Hopkins University},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Allon Therapeutics 2007
Open access · US-GOV
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Effect on Cognitive Function of AL-108 After 12 Weeks of Intranasal Administration in Subjects With Mild Cognitive Impairment
Ageing Research Reviews 2013
Preprint · OA
Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease
University of Utah 2023
Open access · US-GOV
Couples Health Aging, Rhythms and Sleep Study (CHARMS Study)
Edinburgh Research Explorer 2011
Preprint · OA
Dual Tasking and Memory Binding in Alzheimer’s Disease
US Department of Veterans Affairs 1998
Open access · US-GOV
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Steven E Arnold, MD 2020
Open access · US-GOV